NR3C2 and cancer: Recent studies demonstrating the antiproliferative role of MR on colorectal (Zhou et al., 2022), triple negative breast (Jeon et al., 2016), and prostate (Lu et al., 2020) cancer cells further fortify the use of MR as a potential therapeutic agent.